Analysis of the Effects of Different Chemotherapy Methods on Blood Lipid Levels in Breast Cancer Patients
Chemotherapy has adverse effects on the blood lipid levels of premenopausal and postmenopausal breast carcinoma patients and increases the incidence of dyslipidemia. Compared with other regimens, epirubicin+cyclophosphamide sequential paclitaxel regimen has little impact on blood lipid level of breast carcinoma.
Authors
- Jiaqi Mu
- Mai Zhou (ORCID: https://orcid.org/0000-0001-5696-0818)
- G.-M. Jiao
Institutions
- Aviation General Hospital (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/bctt.s456422
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00